Wegovy® Pill

The Wegovy Pill price shown during ordering is the best starting point for comparing total cost. Look at strength, quantity, and total tablets supplied together rather than a single number — a lower price may reflect a lower starting strength, not necessarily better value for the same treatment stage. Wegovy Pill costs can vary by strength and pack size. Because tablets are taken daily rather than weekly, total monthly cost should be compared on a like-for-like basis with the injection rather than assumed to be cheaper or more expensive by default. If you are reviewing cost without insurance, focus on the cash-pay total for the strength and quantity your plan calls for. Do not change strength or switch forms based on price alone — ask your clinician first.

• Medication name: Match Wegovy semaglutide, not another semaglutide brand.
• Strength: Use the mg amount directed by your clinician (1.5 mg, 4 mg, 9 mg, or 25 mg, depending on where you are in the titration schedule).
• Form: Do not treat tablets and the Wegovy injection pen as interchangeable.
• Total cost: Review the final checkout amount before submitting.

All three products contain semaglutide, but they are not interchangeable. Wegovy Pill and Wegovy injection share the same approved use — chronic weight management and cardiovascular risk reduction in adults with obesity or overweight. Rybelsus is a separate oral semaglutide product approved for type 2 diabetes, not for weight management, and is dosed differently. Seeing “semaglutide” on a label is not enough to confirm a product matches your treatment plan.

Switching between any of these products should only happen on your clinician’s direction. Strength, titration schedule, and monitoring needs differ even when the active ingredient name looks the same.

Canadian Insulin is a prescription referral service — we do not dispense, manufacture, prescribe, or ship medications ourselves. We connect you with licensed healthcare providers and independent third-party pharmacies, where legally permitted. All prescribing, dispensing, and delivery is handled by those parties.

• Choose the correct medicine: confirm you are ordering Wegovy Pill (tablet), not Wegovy injection or Rybelsus.
• Match the strength to your clinician’s current directions — 1.5 mg, 4 mg, 9 mg, and 25 mg are the strengths available.
• Confirm quantity (30 tablets per pack).
• Take the tablet in the morning on an empty stomach with up to 4 ounces (about 120 mL) of plain water, then wait at least 30 minutes before eating, drinking anything else, or taking other oral medicines.
• Delayed stomach emptying can affect how other oral medicines are absorbed — tell your care team about everything else you take.

Wegovy Pill contains semaglutide, a GLP-1 receptor agonist that acts on hormone pathways involved in appetite and blood-sugar signaling. It is used with a reduced-calorie eating plan and increased physical activity for chronic weight management in certain adults with obesity, or are overweight and have a weight-related health condition. It is also indicated to reduce the risk of major adverse cardiovascular events in adults with established cardiovascular disease and are either obesity or overweight. Wegovy Pill is not indicated for type 2 diabetes and is not approved for use in people under 18. A medicine labeled for diabetes, such as Rybelsus, should not be substituted for Wegovy Pill unless your clinician specifically changes your treatment plan. Related: Obesity · Overweight · Weight Management

• Active ingredient: Semaglutide, GLP-1 receptor agonist
• Form: Oral tablet
• Strengths available: 1.5 mg, 4 mg, 9 mg, and 25 mg (the full four-step titration schedule)
• Frequency: Once daily, taken on an empty stomach
• Substitution caution: Rybelsus (oral semaglutide for type 2 diabetes) and Wegovy injection are not equivalent substitutes — do not switch forms without clinician direction

See: Weight Management

Wegovy Pill is stored at room temperature (68–77°F / 20–25°C) in a dry place, away from heat, moisture, and direct light. Unlike the Wegovy injection pen, the tablet form does not require refrigeration at any point — keep it in its original container with the lid closed. Never expose tablets to freezing or to temperatures above 86°F (30°C). Check the expiration date printed on the package before use, and dispose of any unused tablets through a pharmacy take-back program rather than household trash.

Common Wegovy Pill side effects include nausea, diarrhea, vomiting, constipation, stomach pain, altered skin sensations, headache, tiredness, indigestion, dizziness, bloating, belching, gas, and heartburn. These effects tend to be more noticeable during dose increases. Serious warning signs that need prompt medical attention include severe or persistent abdominal pain (possible pancreatitis), upper abdominal pain with fever or yellowing skin (possible gallbladder involvement), signs of an allergic reaction such as swelling or trouble breathing, new or worsening depression or suicidal thoughts, and signs of dehydration or worsening kidney function. Wegovy Pill carries a boxed warning: in rodent studies, semaglutide caused thyroid C-cell tumors; it is unknown whether this risk applies to humans. Wegovy Pill is contraindicated in people with a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2), and in anyone with a known hypersensitivity to semaglutide. Tell your clinician about thyroid disease, pancreatitis, gallbladder disease, kidney problems, diabetic retinopathy, diabetes, mental health history, pregnancy plans, breastfeeding, and all other medicines and supplements you take. Wegovy Pill should not be used during pregnancy.

Semaglutide slows stomach emptying, which can change how other oral medicines are absorbed — this matters most for medicines with a narrow therapeutic index. Tell your care team about all prescription medicines, over-the-counter products, supplements, insulin, sulfonylureas, and any other GLP-1 medicines, including Rybelsus or Wegovy injection. People with type 2 diabetes taking insulin or a sulfonylurea alongside Wegovy Pill may need closer blood-sugar monitoring. Tell your healthcare team about Wegovy Pill before surgery or a procedure requiring anesthesia, since delayed stomach emptying can affect fasting and procedure timing.

Wegovy Pill is one option within prescription weight-management care. It differs from the Wegovy injection pen, from diabetes-labeled semaglutide products like Rybelsus, and from other GLP-1 and weight-management medicines in form, dosing schedule, storage, and monitoring. Do not switch between these options based only on an online comparison — ask your clinician how starting dose, titration, contraindications, and monitoring would change first.

• FDA prescribing information for Wegovy (semaglutide) tablets
• Novo Nordisk manufacturer patient information for Wegovy Pills
• FDA approval announcement, December 2025

This content is for informational purposes only and is not a substitute for professional medical advice.